Literature DB >> 28946214

Circular RNA hsa_circ_0003575 regulates oxLDL induced vascular endothelial cells proliferation and angiogenesis.

Chen-Ye Li1, Lan Ma1, Bo Yu2.   

Abstract

Circular RNAs (circRNAs) are a novel class of RNAs generated from back-splicing and characterized by covalently closed continuous loops. Recently, circRNAs have recently shown large regulation on cardiovascular system, including atherosclerosis. The present study aims to investigate the circRNA expression profile and identify their roles on vascular endothelial cells induced by oxLDL. Human circRNA microarray analysis revealed that total 943 differently expressed circRNAs were screened with 2 fold change. Hsa_circ_0003575 was validated to be significantly up-regulated in oxLDL induced HUVECs. Loss-of-function experiments indicated that hsa_circ_0003575 silencing promoted the proliferation and angiogenesis ability of HUVECs. Bioinformatics online programs predicted the potential circRNA-miRNA-mRNA network for hsa_circ_0003575. In summary, circRNA microarray analysis reveals the expression profiles of HUVECs and verifies the role of hsa_circ_0003575 on HUVECs, providing a therapeutic strategy for vascular endothelial cell injury of atherosclerosis.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Circular RNAs; Vascular endothelial cells; hsa_circ_0003575; oxLDL

Mesh:

Substances:

Year:  2017        PMID: 28946214     DOI: 10.1016/j.biopha.2017.09.064

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  66 in total

1.  Circular RNA circDENND2A protects H9c2 cells from oxygen glucose deprivation-induced apoptosis through sponging microRNA-34a.

Authors:  Yuanxia Shao; Peng Zhong; Li Sheng; Hongjian Zheng
Journal:  Cell Cycle       Date:  2019-12-27       Impact factor: 4.534

Review 2.  Role of circular RNAs in cardiovascular diseases.

Authors:  Xue Gong; Gengze Wu; Chunyu Zeng
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-17

3.  Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Authors:  Suowen Xu; Danielle Kamato; Peter J Little; Shinichi Nakagawa; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Pharmacol Ther       Date:  2018-11-13       Impact factor: 12.310

4.  Astragaloside IV alleviates atherosclerosis through targeting circ_0000231/miR-135a-5p/CLIC4 axis in AS cell model in vitro.

Authors:  Xiao Shao; Zhaozheng Liu; Shanshan Liu; Na Lin; Yue Deng
Journal:  Mol Cell Biochem       Date:  2021-01-13       Impact factor: 3.396

5.  Circ_USP36/miR-182-5p/KLF5 axis regulates the ox-LDL-induced injury in human umbilical vein smooth muscle cells.

Authors:  Qiang Zhao; Ying-Hong Lu; Xin Wang; Xue-Jun Zhang
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

6.  Microarray profiles reveal that circular RNA hsa_circ_0007385 functions as an oncogene in non-small cell lung cancer tumorigenesis.

Authors:  Ming-Ming Jiang; Zhi-Tao Mai; Shan-Zhi Wan; Yu-Min Chi; Xin Zhang; Bao-Hua Sun; Qing-Guo Di
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-25       Impact factor: 4.553

7.  Down-regulation of circ-PRKCI inhibits cell migration and proliferation in Hirschsprung disease by suppressing the expression of miR-1324 target PLCB1.

Authors:  Lingling Zhou; Yang Li; Weiwei Jiang; Hua Zhang; Zechao Wen; Yang Su; Feng Wu; Zhengke Zhi; Qiyang Shen; Hongxing Li; Xiaoqun Xu; Weibing Tang
Journal:  Cell Cycle       Date:  2018-07-09       Impact factor: 4.534

Review 8.  The Function and Therapeutic Potential of Circular RNA in Cardiovascular Diseases.

Authors:  Kai Wang; Xiang-Qian Gao; Tao Wang; Lu-Yu Zhou
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-16       Impact factor: 3.727

Review 9.  Circular RNAs open a new chapter in cardiovascular biology.

Authors:  Simona Aufiero; Yolan J Reckman; Yigal M Pinto; Esther E Creemers
Journal:  Nat Rev Cardiol       Date:  2019-08       Impact factor: 32.419

Review 10.  Non-coding RNAs in cardiovascular cell biology and atherosclerosis.

Authors:  Francesca Fasolo; Karina Di Gregoli; Lars Maegdefessel; Jason L Johnson
Journal:  Cardiovasc Res       Date:  2019-10-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.